Ekuiti Nasional (Ekuinas), a private equity company owned by the Malaysian government, has acquired a controlling stake in a local pharmaceutical company, Medispec, an enterprise valued at MYR88.5 million (US$21.9 million).
With a track record spanning more than 35 years, Medispec is a leading distributor of healthcare and pharmaceutical products in Malaysia across clinics, pharmacies, and private and public hospitals. It offers more than 100 drugs and 30 supplements under both prescription and over-the-counter categories.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.